Download PDF
Thromb Haemost 2018; 118(07): 1305-1315
DOI: 10.1055/s-0038-1655766
Stroke, Systemic or Venous Thromboembolism
Georg Thieme Verlag KG Stuttgart · New York

Factor VIII, Protein C and Cardiovascular Disease Risk: The REasons for Geographic and Racial Differences in Stroke Study (REGARDS)

Neil A. Zakai
1   Department of Medicine, Larner College of Medicine, University of Vermont, Burlington, Vermont, United States
2   Department of Pathology and Laboratory Medicine, University of Vermont, Burlington, Vermont, United States
,
Suzanne E. Judd
3   School of Public Health, Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama, United States
,
Brett Kissela
4   Department of Neurology and Rehabilitation Medicine, University of Cincinnati, Cincinnati, Ohio, United States
,
George Howard
3   School of Public Health, Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama, United States
,
Monika M. Safford
5   Division of General Internal Medicine, Department of Medicine, Weill Cornell Medical College, Cornell University, New York, New York, United States
,
Mary Cushman
1   Department of Medicine, Larner College of Medicine, University of Vermont, Burlington, Vermont, United States
› Author Affiliations Funding Funding was received solely from the National Institutes of Health, Department of Health and Human Service, Bethesda, MD, USA. Grant numbers: U01 NS041588, K08 HL096841 and R01 HL080477. This research project is supported by a cooperative agreement U01 NS041588 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service, Bethesda, MD, USA. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health. Representatives of the funding agency have been involved in the review of the manuscript but not directly involved in the collection, management, analysis or interpretation of the data. The authors thank the other investigators, the staff and the participants of the REGARDS study for their valuable contributions. A full list of participating REGARDS investigators and institutions can be found at http://www.regardsstudy.org.
Additional funding was provided by an investigator-initiated grant-in-aid K08HL096841 and R01HL080477 from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Service, Bethesda, MD, USA. Representatives from the National Heart, Lung, and Blood Institute did not have any role in the design and conduct of the study, the collection, management, analysis and interpretation of the data, or the preparation of the manuscript.
Further Information

Publication History

21 November 2017

15 April 2018

Publication Date:
11 June 2018 (online)

    Permissions and Reprints

Abstract

Background Haemostatic balance represented by low protein C (PC) and elevated factor VIII (FVIII) has been inconsistently associated with stroke and coronary heart disease (CHD) risk.

Objective This article assesses whether an elevated FVIII and a low PC would increase cardiovascular risk more than either individually.

Patients and Methods REGARDS recruited 30,239 black and white U.S. participants aged ≥ 45 years between 2003 and 2007. FVIII and PC were measured in a case–cohort sample of 646 stroke, 654 CHD, and a 1,104-person random sample with follow-up for approximately 4.5 years. Hazard ratios (HRs) were estimated using Cox models adjusted for demographic and cardiovascular risk factors.

Results Elevated FVIII (per standard deviation [SD] increase) was associated with increased risk of both stroke (HR, 1.26; 95% confidence interval [CI], 1.08, 1.46) and CHD (HR, 1.52; 95% CI, 1.29, 1.79), while there was no association of PC per SD decrease. For PC, there was a trend towards increased cardiovascular disease risk in the lowest values (bottom 5%). For stroke, there was no interaction between FVIII and low PC (p interaction = 0.55). For CHD, the adjusted HR of FVIII per SD increase was significantly greater with PC in the bottom 5% (HR, 3.59; 95% CI, 1.39, 8.29) than PC in the upper 95% (HR, 1.45; 95% CI, 1.23, 1.71; p interaction = 0.07).

Conclusion Higher FVIII was associated with both CHD and stroke risk and the risk potentiated by low PC for CHD. Findings demonstrate that risks for cardiovascular diseases conferred by adverse levels of haemostasis biomarkers may be augmented by levels of other biomarkers.

Keywords

coronary disease - epidemiology - factor VIII - protein C - stroke

Authors' Contributions

Obtained funding: N.A. Zakai, M.M. Safford and G. Howard. Research design and methods: All authors. Statistical analyses: N.A. Zakai and S.E. Judd. Initial manuscript draft: N.A. Zakai. Critical revision and scientific review of the manuscript: All authors.


 

  • References

  • 1 Dzau VJ, Antman EM, Black HR. , et al. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease). Circulation 2006; 114 (25) 2850-2870
    CrossrefPubMedGoogle Scholar
  • 2 Smith A, Patterson C, Yarnell J, Rumley A, Ben-Shlomo Y, Lowe G. Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study. Circulation 2005; 112 (20) 3080-3087
    CrossrefPubMedGoogle Scholar
  • 3 Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG. Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: the Edinburgh Artery Study. Circulation 2007; 115 (16) 2119-2127
    CrossrefPubMedGoogle Scholar
  • 4 Zakai NA, Katz R, Jenny NS. , et al. Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study. J Thromb Haemost 2007; 5 (06) 1128-1135
    CrossrefPubMedGoogle Scholar
  • 5 Smith NL, Bis JC, Biagiotti S. , et al. Variation in 24 hemostatic genes and associations with non-fatal myocardial infarction and ischemic stroke. J Thromb Haemost 2008; 6 (01) 45-53
    PubMedGoogle Scholar
  • 6 Kucharska-Newton AM, Couper DJ, Pankow JS. , et al. Hemostasis, inflammation, and fatal and nonfatal coronary heart disease: long-term follow-up of the atherosclerosis risk in communities (ARIC) cohort. Arterioscler Thromb Vasc Biol 2009; 29 (12) 2182-2190
    CrossrefPubMedGoogle Scholar
  • 7 Bhatia M, Rothwell PM. A systematic comparison of the quality and volume of published data available on novel risk factors for stroke versus coronary heart disease. Cerebrovasc Dis 2005; 20 (03) 180-186
    PubMedGoogle Scholar
  • 8 Soliman EZ, Safford MM, Muntner P. , et al. Atrial fibrillation and the risk of myocardial infarction. JAMA Intern Med 2014; 174 (01) 107-114
    CrossrefPubMedGoogle Scholar
  • 9 Kumar G, Goyal MK. Warfarin versus aspirin for prevention of stroke in heart failure: a meta-analysis of randomized controlled clinical trials. J Stroke Cerebrovasc Dis 2013; 22 (08) 1279-1287
    CrossrefPubMedGoogle Scholar
  • 10 Force USPST. ; US Preventive Services Task Force. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009; 150 (06) 396-404
    CrossrefPubMedGoogle Scholar
  • 11 Soare AM, Popa C. Deficiencies of proteins C, S and antithrombin and activated protein C resistance--their involvement in the occurrence of Arterial thromboses. J Med Life 2010; 3 (04) 412-415
    PubMedGoogle Scholar
  • 12 Folsom AR, Ohira T, Yamagishi K, Cushman M. Low protein C and incidence of ischemic stroke and coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. J Thromb Haemost 2009; 7 (11) 1774-1778
    CrossrefPubMedGoogle Scholar
  • 13 Folsom AR, Delaney JA, Lutsey PL. , et al; Multiethnic Study of Atherosclerosis Investigators. Associations of factor VIIIc, D-dimer, and plasmin-antiplasmin with incident cardiovascular disease and all-cause mortality. Am J Hematol 2009; 84 (06) 349-353
    CrossrefPubMedGoogle Scholar
  • 14 Rasche H. Haemostasis and thrombosis: an overview. Eur Heart J Suppl 2001; 3: 3-7
    PubMedGoogle Scholar
  • 15 Esmon CT. The protein C pathway. Chest 2003; 124 (3, Suppl): 26S-32S
    CrossrefPubMedGoogle Scholar
  • 16 Howard VJ, Cushman M, Pulley L. , et al. The REasons for Geographic and Racial Differences in Stroke study: objectives and design. Neuroepidemiology 2005; 25 (03) 135-143
    CrossrefPubMedGoogle Scholar
  • 17 Howard VJ, Kleindorfer DO, Judd SE. , et al. Disparities in stroke incidence contributing to disparities in stroke mortality. Ann Neurol 2011; 69 (04) 619-627
    CrossrefPubMedGoogle Scholar
  • 18 Barlow WE, Ichikawa L, Rosner D, Izumi S. Analysis of case-cohort designs. J Clin Epidemiol 1999; 52 (12) 1165-1172
    CrossrefPubMedGoogle Scholar
  • 19 Kulathinal S, Karvanen J, Saarela O, Kuulasmaa K. Case-cohort design in practice - experiences from the MORGAM Project. Epidemiol Perspect Innov 2007; 4: 15
    CrossrefPubMedGoogle Scholar
  • 20 Zakai NA, Judd SE, Alexander K. , et al. ABO blood type and stroke risk: the REasons for Geographic and Racial Differences in Stroke Study. J Thromb Haemost 2014; 12 (04) 564-570
    CrossrefPubMedGoogle Scholar
  • 21 Gillett SR, Boyle RH, Zakai NA, McClure LA, Jenny NS, Cushman M. Validating laboratory results in a national observational cohort study without field centers: the Reasons for Geographic and Racial Differences in Stroke cohort. Clin Biochem 2014; 47 (16-17): 243-246
    CrossrefPubMedGoogle Scholar
  • 22 Howard G, Cushman M, Kissela BM. , et al; REasons for Geographic And Racial Differences in Stroke (REGARDS) Investigators. Traditional risk factors as the underlying cause of racial disparities in stroke: lessons from the half-full (empty?) glass. Stroke 2011; 42 (12) 3369-3375
    CrossrefPubMedGoogle Scholar
  • 23 Safford MM, Brown TM, Muntner PM. , et al; REGARDS Investigators. Association of race and sex with risk of incident acute coronary heart disease events. JAMA 2012; 308 (17) 1768-1774
    CrossrefPubMedGoogle Scholar
  • 24 Luepker RV, Apple FS, Christenson RH. , et al; AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation 2003; 108 (20) 2543-2549
    CrossrefPubMedGoogle Scholar
  • 25 Boekholdt SM, Kramer MH. Arterial thrombosis and the role of thrombophilia. Semin Thromb Hemost 2007; 33 (06) 588-596
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 Benjamin EJ, Blaha MJ, Chiuve SE. , et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2017 Update: a report from the American Heart Association. Circulation 2017; 135 (10) e146-e603
    CrossrefPubMedGoogle Scholar
  • 27 Olson NC, Cushman M, Judd SE. , et al. Associations of coagulation factors IX and XI levels with incident coronary heart disease and ischemic stroke: the REGARDS study. J Thromb Haemost 2017; 15 (06) 1086-1094
    CrossrefPubMedGoogle Scholar
  • 28 Zakai NA, McClure LA, Judd SE. , et al. D-dimer and the risk of stroke and coronary heart disease. The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Thromb Haemost 2017; 117 (03) 618-624
    Article in Thieme ConnectPubMedGoogle Scholar
  • 29 Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation 2005; 111 (25) 3481-3488
    CrossrefPubMedGoogle Scholar
  • 30 Petty GW, Brown Jr RD, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke 1999; 30 (12) 2513-2516
    CrossrefPubMedGoogle Scholar
  • 31 Peyvandi F, Palla R, Menegatti M. , et al; European Network of Rare Bleeding Disorders Group. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. J Thromb Haemost 2012; 10 (04) 615-621
    CrossrefPubMedGoogle Scholar
  • 32 Srivastava A, Brewer AK, Mauser-Bunschoten EP. , et al; Treatment Guidelines Working Group on Behalf of The World Federation Of Hemophilia. Guidelines for the management of hemophilia. Haemophilia 2013; 19 (01) e1-e47
    CrossrefPubMedGoogle Scholar
  • 33 Tsai AW, Cushman M, Rosamond WD. , et al. Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med 2002; 113 (08) 636-642
    CrossrefPubMedGoogle Scholar
  • 34 Kamphuisen PW, ten Cate H. Cardiovascular risk in patients with hemophilia. Blood 2014; 123 (09) 1297-1301
    CrossrefPubMedGoogle Scholar
  • 35 Zakai NA, Olson NC, Judd SE. , et al. Haemostasis biomarkers and risk of intracerebral haemorrhage in the REasons for Geographic and Racial Differences in Stroke Study. Thromb Haemost 2017; 117 (09) 1808-1815
    Article in Thieme ConnectPubMedGoogle Scholar
  • 36 Ten Cate H, Hemker HC. Thrombin generation and atherothrombosis: what does the evidence indicate?. J Am Heart Assoc 2016; 5 (08) e003553
    CrossrefPubMedGoogle Scholar
  • 37 Zakai NA, Ohira T, White R, Folsom AR, Cushman M. Activated partial thromboplastin time and risk of future venous thromboembolism. Am J Med 2008; 121 (03) 231-238
    CrossrefPubMedGoogle Scholar